CL&M Assists Trinity Biotech plc with a Public Offering
We advised our client Trinity Biotech plc (NASDAQ: TAB), an Irish diagnostic company, in connection with a public offering of 2,675,000 American Depositary Shares for $23 million, which closed on April 11, 2006. Roth Capital Partners and J&E Davy acted as placement agents for investors located in the United States, United Kingdom, Ireland, France and Switzerland. The CL&M team lead by Alan J. Bernstein, included Peter Flägel, Rick Horne and Pamela Shelinsky.
We continue to monitor and report on recent COVID-19 developments. Please refer to our Response Group’s homepage, where you'll find advisories from numerous attorneys on a wide range of subjects.